CD80 (P33681) variants and mutations
CD80 (also known as P33681) is a human protein-coding gene encoding a t-lymphocyte activation antigen protein. It provides costimulatory signals to T cells through CD28 and inhibitory signals through CTLA-4, helping determine the strength and duration of adaptive immune responses. This pathway is therapeutically manipulated by checkpoint inhibitors and CTLA-4-Ig fusion proteins. This analysis covers 623 CD80 variants and mutations. Of these, 94% have computational variant effect predictions. Disease context includes rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. Example CD80 variants include M1?, H3D, and R5P.
Variant analysis overview
- Gene: CD80
- Protein: P33681
- UniProt accession: P33681
- Organism: Homo sapiens
- Variants analyzed: 623
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 371 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 111 synonymous variants; 108 missense variants; 5 stop-gained variants; 6 in-frame deletions; 2 splice-region variants; 18 frameshift variants
- Prediction scores: 587 variants have prediction scores (94% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, immune system disorder, hypothyroidism, cancer, kidney transplant, systemic lupus erythematosus, non-Hodgkin lymphoma, Sjogren syndrome, temporal arteritis, heart transplant rejection.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 2 domains; 9 post-translational modification sites.
- Structural context: 455 variants have structural context.
- PTM context: 21 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CD80 variants
Examples include M1?, H3D, R5P, R5Q, R5W, G8E, G8R, S10P. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV10457
- H3D (p.His3Asp), TOPMed rs1664503554, gnomAD rs1664503554, REVEL 0.07, MetaLR 0.02
- R5P (p.Arg5Pro), 1000Genomes rs267599556, ExAC rs267599556, TOPMed rs267599556, REVEL 0.02, MetaLR 0.02
- R5Q (p.Arg5Gln), rs267599556, 1000Genomes rs267599556, ExAC rs267599556, TOPMed rs267599556, REVEL 0.01, MetaLR 0.02, Variant assessed as somatic; moderate impact.
- R5W (p.Arg5Trp), ExAC rs753619011, TOPMed rs753619011, gnomAD rs753619011, REVEL 0.10, MetaLR 0.03, Likely benign, not specified
- G8E (p.Gly8Glu), cosmic curated COSV51802, TOPMed rs1048390794, gnomAD rs1048390794, REVEL 0.07, MetaLR 0.04
- G8R (p.Gly8Arg), ExAC rs772876009, gnomAD rs772876009, REVEL 0.02, MetaLR 0.02
- S10P (p.Ser10Pro), ExAC rs771745016, TOPMed rs771745016, gnomAD rs771745016, REVEL 0.03, MetaLR 0.01
- S12A (p.Ser12Ala), cosmic curated COSV51803
- S12F (p.Ser12Phe), TOPMed rs1274319251, gnomAD rs1274319251, REVEL 0.03, MetaLR 0.03
- K13E (p.Lys13Glu), cosmic curated COSV51801
- K13N (p.Lys13Asn), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- K13Q (p.Lys13Gln), gnomAD rs1444553508, REVEL 0.05, MetaLR 0.04
- C14R (p.Cys14Arg), Ensembl rs2082272003, REVEL 0.04, MetaLR 0.02
- P15S (p.Pro15Ser), NCI-TCGA Cosmic COSV5180, cosmic curated COSV51801, REVEL 0.08, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- Y16S (p.Tyr16Ser), TOPMed rs2082271968, MetaLR 0.02, MetaSVM -1.00
- L17I (p.Leu17Ile), cosmic curated COSV99958
- L17R (p.Leu17Arg), TOPMed rs544665850, gnomAD rs544665850, REVEL 0.06, MetaLR 0.03
- N18S (p.Asn18Ser), TOPMed rs1256099911, gnomAD rs1256099911, REVEL 0.02, MetaLR 0.01
- F19L (p.Phe19Leu), rs1203312130, NCI-TCGA Cosmic COSV5180, cosmic curated COSV51801, REVEL 0.03, MetaLR 0.01, Variant assessed as somatic; moderate impact.
- F19S (p.Phe19Ser), TOPMed rs2082271884, MetaLR 0.05, MetaSVM -1.02
- F20I (p.Phe20Ile), ExAC rs749632025, TOPMed rs749632025, gnomAD rs749632025, REVEL 0.02, MetaLR 0.02
- F20V (p.Phe20Val), ExAC rs749632025, TOPMed rs749632025, gnomAD rs749632025, REVEL 0.05, MetaLR 0.03
- L22I (p.Leu22Ile), 1000Genomes rs151042794, ESP rs151042794, ExAC rs151042794, TOPMed rs151042794, REVEL 0.07, MetaLR 0.09, Uncertain significance, not specified
- L23F (p.Leu23Phe), ExAC rs770316948, TOPMed rs770316948, gnomAD rs770316948, REVEL 0.08, MetaLR 0.04
- V24L (p.Val24Leu), 1000Genomes rs553548247, ExAC rs553548247, gnomAD rs553548247, cosmic curated COSV51802, REVEL 0.03, MetaLR 0.03
- V24M (p.Val24Met), 1000Genomes rs553548247, ExAC rs553548247, gnomAD rs553548247, REVEL 0.06, MetaLR 0.04
- L25M (p.Leu25Met), cosmic curated COSV10507, REVEL 0.09, MetaLR 0.15
- A26D (p.Ala26Asp), cosmic curated COSV51802, MetaLR 0.06, MetaSVM -1.05
- G27C (p.Gly27Cys), cosmic curated COSV51803
- G27D (p.Gly27Asp), gnomAD rs1312884053, REVEL 0.09, MetaLR 0.06, Uncertain significance, not specified
- L28F (p.Leu28Phe), gnomAD rs1379920549, REVEL 0.02, MetaLR 0.11
- L28V (p.Leu28Val), cosmic curated COSV51801
- H30N (p.His30Asn), TOPMed rs2082271655, gnomAD rs2082271655, REVEL 0.01, MetaLR 0.02
- H30Q (p.His30Gln), TOPMed rs1297691108, gnomAD rs1297691108, REVEL 0.01, MetaLR 0.02
- F31L (p.Phe31Leu), gnomAD rs1440204200, REVEL 0.04, MetaLR 0.03
- C32S (p.Cys32Ser), gnomAD rs1159490683, NCI-TCGA Cosmic COSV5180, cosmic curated COSV51801, REVEL 0.06, MetaLR 0.01, Variant assessed as somatic; moderate impact.
- S33* (p.Ser33Ter), gnomAD rs1356561145, CADD 35.00
- S33L (p.Ser33Leu), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- G34D (p.Gly34Asp), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, Variant assessed as somatic; moderate impact.
- G34S (p.Gly34Ser), Ensembl rs2082271582
- V35A (p.Val35Ala), ESP rs142958721, ExAC rs142958721, TOPMed rs142958721, gnomAD rs142958721, REVEL 0.10, MetaLR 0.03
- V35D (p.Val35Asp), ESP rs142958721, ExAC rs142958721, TOPMed rs142958721, gnomAD rs142958721, MetaLR 0.03, MetaSVM -1.00
- V35I (p.Val35Ile), TOPMed rs2082191525, REVEL 0.02, MetaLR 0.01
- I36S (p.Ile36Ser), gnomAD 3-119544862-TA-T, CADD 16.10
- H37N (p.His37Asn), cosmic curated COSV99958, MetaLR 0.04, MetaSVM -0.98
- H37P (p.His37Pro), ESP rs62264489, ExAC rs62264489, TOPMed rs62264489, gnomAD rs62264489, REVEL 0.02, MetaLR 0.10
- H37H (p.His37His), rs775093170, gnomAD 3-119544857-G-A, CADD 1.53
- H37L (p.His37Leu), gnomAD 3-119544858-T-A, REVEL 0.03, MetaLR 0.13
- H37R (p.His37Arg), gnomAD 3-119544858-T-C, REVEL 0.02, MetaLR 0.09
- V38M (p.Val38Met), ESP rs146886200, TOPMed rs146886200, gnomAD rs146886200, REVEL 0.27, MetaLR 0.43
- V38V (p.Val38Val), gnomAD 3-119544854-C-A, CADD 6.16
- V38L (p.Val38Leu), gnomAD 3-119544856-C-G, REVEL 0.20, MetaLR 0.27
- T39N (p.Thr39Asn), gnomAD rs1224527849, REVEL 0.02, MetaLR 0.14
- K40K (p.Lys40Lys), rs770194191, gnomAD 3-119544848-C-T, CADD 7.76
- K40* (p.Lys40Ter), gnomAD 3-119544850-T-A, CADD 38.00
- E41D (p.Glu41Asp), gnomAD rs1208402318, REVEL 0.02, MetaLR 0.14
- E41G (p.Glu41Gly), Ensembl rs2082191384
- E41K (p.Glu41Lys), cosmic curated COSV10507, Ensembl rs867968226
- E41Q (p.Glu41Gln), gnomAD 3-119544847-C-G, REVEL 0.03, MetaLR 0.09
- V42L (p.Val42Leu), gnomAD rs2082191354
- V42* (p.Val42Ter), gnomAD 3-119544844-CT-C, CADD 14.00
- E44* (p.Glu44Ter), NCI-TCGA Cosmic COSV5180, cosmic curated COSV51802, Variant assessed as somatic; high impact.
- V45M (p.Val45Met), cosmic curated COSV51802, ExAC rs746220473, gnomAD rs746220473, REVEL 0.09, MetaLR 0.13
- V45V (p.Val45Val), rs2228017, gnomAD 3-119544833-C-T, CADD 3.17
- V45E (p.Val45Glu), gnomAD 3-119544834-A-T, REVEL 0.06, MetaLR 0.12
- V45A (p.Val45Ala), gnomAD 3-119544834-A-G, REVEL 0.02, MetaLR 0.13
- A46P (p.Ala46Pro), cosmic curated COSV10585
- T47A (p.Thr47Ala), 1000Genomes rs183378805, ESP rs183378805, ExAC rs183378805, TOPMed rs183378805, REVEL 0.05, MetaLR 0.11, Uncertain significance, not specified
- T47M (p.Thr47Met), 1000Genomes rs201443429, ESP rs201443429, ExAC rs201443429, TOPMed rs201443429, REVEL 0.08, MetaLR 0.16
- T47T (p.Thr47Thr), rs777859790, gnomAD 3-119544827-C-A, CADD 1.68
- L48P (p.Leu48Pro), 1000Genomes rs142547094, ExAC rs142547094, gnomAD rs142547094, REVEL 0.67, MetaLR 0.71
- L48L (p.Leu48Leu), gnomAD 3-119544824-C-T, CADD 4.69
- S49Y (p.Ser49Tyr), gnomAD rs1285569312, REVEL 0.41, MetaLR 0.49
- C50F (p.Cys50Phe), Ensembl rs1022857991, MetaLR 0.59, MetaSVM 0.39
- C50R (p.Cys50Arg), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, REVEL 0.66, MetaLR 0.57, Variant assessed as somatic; moderate impact.
- C50C (p.Cys50Cys), rs1201063538, gnomAD 3-119544818-A-G, CADD 9.20
- G51C (p.Gly51Cys), cosmic curated COSV99958
- G51V (p.Gly51Val), gnomAD 3-119544815-AC-A, CADD 22.30
- H52N (p.His52Asn), gnomAD rs1387758204, REVEL 0.28, MetaLR 0.21
- H52H (p.His52His), rs2082191031, gnomAD 3-119544812-G-A, CADD 8.58
- H52D (p.His52Asp), gnomAD 3-119544814-G-C, REVEL 0.33, MetaLR 0.21
- N53S (p.Asn53Ser), Ensembl rs1014349892, REVEL 0.27, MetaLR 0.25
- V54A (p.Val54Ala), NCI-TCGA Cosmic COSV5180, cosmic curated COSV51802, MetaLR 0.11, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
- V54I (p.Val54Ile), cosmic curated COSV99958, REVEL 0.01, MetaLR 0.03
- V54G (p.Val54Gly), gnomAD 3-119544807-A-C, REVEL 0.04, MetaLR 0.14
- V56A (p.Val56Ala), TOPMed rs1384830720, gnomAD rs1384830720, REVEL 0.01, MetaLR 0.06
- V56G (p.Val56Gly), gnomAD 3-119544790-CCAGC, CADD 24.10
- E57K (p.Glu57Lys), cosmic curated COSV10585
- E57A (p.Glu57Ala), gnomAD 3-119544798-T-G, REVEL 0.07, MetaLR 0.09
- E58D (p.Glu58Asp), ExAC rs756028722, TOPMed rs756028722, gnomAD rs756028722, REVEL 0.09, MetaLR 0.15
- E58G (p.Glu58Gly), TOPMed rs931956626, gnomAD rs931956626, REVEL 0.35, MetaLR 0.42
- E58Q (p.Glu58Gln), TOPMed rs2082190989, REVEL 0.21, MetaLR 0.27
- E58V (p.Glu58Val), TOPMed rs931956626, gnomAD rs931956626, REVEL 0.32, MetaLR 0.43
- E58E (p.Glu58Glu), rs756028722, gnomAD 3-119544794-C-T, CADD 6.08
- L59L (p.Leu59Leu), gnomAD 3-119544793-G-A, CADD 8.03
- A60T (p.Ala60Thr), TOPMed rs1390128025, gnomAD rs1390128025, REVEL 0.02, MetaLR 0.08
- A60V (p.Ala60Val), gnomAD 3-119544789-G-A, REVEL 0.05, MetaLR 0.17
- Q61E (p.Gln61Glu), gnomAD rs2082190917, REVEL 0.07, MetaLR 0.07
- Q61R (p.Gln61Arg), ExAC rs750178788, TOPMed rs750178788, gnomAD rs750178788, REVEL 0.03, MetaLR 0.07
- T62A (p.Thr62Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T62I (p.Thr62Ile), TOPMed rs1479901177, gnomAD rs1479901177, REVEL 0.05, MetaLR 0.09
- T62S (p.Thr62Ser), TOPMed rs1479901177, gnomAD rs1479901177, REVEL 0.05, MetaLR 0.09
- R63C (p.Arg63Cys), TOPMed rs1426836107, gnomAD rs1426836107, REVEL 0.47, MetaLR 0.47, Uncertain significance, not specified
- R63H (p.Arg63His), cosmic curated COSV51801, ExAC rs767373131, TOPMed rs767373131, gnomAD rs767373131, REVEL 0.41, MetaLR 0.50
- R63L (p.Arg63Leu), ExAC rs767373131, TOPMed rs767373131, gnomAD rs767373131, REVEL 0.41, MetaLR 0.43
- R63R (p.Arg63Arg), rs1473756464, gnomAD 3-119544779-G-T, CADD 1.37
- R63P (p.Arg63Pro), gnomAD 3-119544780-C-G, REVEL 0.43, MetaLR 0.50
- I64I (p.Ile64Ile), rs895447298, gnomAD 3-119544776-G-A, CADD 8.56
- Y65* (p.Tyr65Ter), cosmic curated COSV10725
- Y65C (p.Tyr65Cys), cosmic curated COSV10725, REVEL 0.70, MetaLR 0.47
- Y65H (p.Tyr65His), gnomAD rs1433518531, REVEL 0.57, MetaLR 0.44
- Y65Y (p.Tyr65Tyr), rs1437854677, gnomAD 3-119544773-G-A, CADD 7.47
- W66G (p.Trp66Gly), gnomAD 3-119544772-A-C, REVEL 0.79, MetaLR 0.90
- Q67Q (p.Gln67Gln), gnomAD 3-119544767-T-C, CADD 10.30
- K68K (p.Lys68Lys), rs370099351, gnomAD 3-119544764-C-T, CADD 6.85
- E69K (p.Glu69Lys), Ensembl rs375549265
- E69del (p.Glu69del), gnomAD 3-119544760-TCTC-, CADD 12.70
- E69E (p.Glu69Glu), gnomAD 3-119544761-C-T, CADD 3.96
- K70N (p.Lys70Asn), NCI-TCGA Cosmic COSV5180, MetaLR 0.06, MetaSVM -1.09, Variant assessed as somatic; moderate impact.
- K70R (p.Lys70Arg), rs775739462, gnomAD 3-119544759-T-TTC, CADD 22.50
- K71E (p.Lys71Glu), TOPMed rs2082190730
- K71Q (p.Lys71Gln), gnomAD 3-119544757-T-G, REVEL 0.06, MetaLR 0.11
- M72I (p.Met72Ile), 1000Genomes rs554004644, ExAC rs554004644, gnomAD rs554004644, REVEL 0.10, MetaLR 0.23
- M72V (p.Met72Val), gnomAD 3-119544754-T-C, REVEL 0.06, MetaLR 0.12
- V73M (p.Val73Met), cosmic curated COSV51803
- V73A (p.Val73Ala), gnomAD 3-119544750-A-G, REVEL 0.40, MetaLR 0.33
- L74P (p.Leu74Pro), ExAC rs763700778, gnomAD rs763700778, REVEL 0.50, MetaLR 0.46
- M76L (p.Met76Leu), ExAC rs762428605, gnomAD rs762428605, MetaLR 0.08, MetaSVM -1.03
- M76V (p.Met76Val), ExAC rs762428605, gnomAD rs762428605, REVEL 0.06, MetaLR 0.06
- M77I (p.Met77Ile), TOPMed rs1321647455, gnomAD rs1321647455, MetaLR 0.11, MetaSVM -0.95
- M77T (p.Met77Thr), TOPMed rs1320277833, gnomAD rs1320277833, REVEL 0.07, MetaLR 0.15
- M77K (p.Met77Lys), gnomAD 3-119544738-A-T, REVEL 0.15, MetaLR 0.19
- S78T (p.Ser78Thr), NCI-TCGA Cosmic COSV5180, cosmic curated COSV51803, Variant assessed as somatic; moderate impact.
- G79A (p.Gly79Ala), gnomAD 3-119544732-C-G, REVEL 0.20, MetaLR 0.43
- D80E (p.Asp80Glu), cosmic curated COSV51802
- D80D (p.Asp80Asp), gnomAD 3-119544728-G-A, CADD 0.91
- D80N (p.Asp80Asn), gnomAD 3-119544730-C-T, REVEL 0.04, MetaLR 0.08
- M81I (p.Met81Ile), TOPMed rs2082190659, gnomAD rs2082190659, REVEL 0.03, MetaLR 0.13
- M81K (p.Met81Lys), gnomAD 3-119544726-A-T, REVEL 0.02, MetaLR 0.08
- M81V (p.Met81Val), gnomAD 3-119544727-T-C, REVEL 0.03, MetaLR 0.06
- N82I (p.Asn82Ile), 1000Genomes rs140149683, ESP rs140149683, ExAC rs140149683, TOPMed rs140149683, REVEL 0.06, MetaLR 0.19
- I83T (p.Ile83Thr), Ensembl rs2107744977, REVEL 0.18, MetaLR 0.20
- I83M (p.Ile83Met), gnomAD 3-119544719-T-C, REVEL 0.19, MetaLR 0.25
- P85L (p.Pro85Leu), cosmic curated COSV10507, REVEL 0.06, MetaLR 0.22
- P85P (p.Pro85Pro), rs764862930, gnomAD 3-119544713-G-A, CADD 5.49
- E86A (p.Glu86Ala), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, Variant assessed as somatic; moderate impact.
- E86K (p.Glu86Lys), cosmic curated COSV51801, ESP rs368745104, ExAC rs368745104, TOPMed rs368745104, REVEL 0.03, MetaLR 0.04, Likely benign, not specified
- E86Q (p.Glu86Gln), ESP rs368745104, ExAC rs368745104, TOPMed rs368745104, gnomAD rs368745104, MetaLR 0.12, MetaSVM -0.96, Likely benign
- E86E (p.Glu86Glu), gnomAD 3-119544710-C-T, CADD 6.35
- E86G (p.Glu86Gly), gnomAD 3-119544711-T-C, REVEL 0.02, MetaLR 0.11
- E86* (p.Glu86Ter), gnomAD 3-119544712-C-A, CADD 30.00
- Y87* (p.Tyr87Ter), ExAC rs776993724, TOPMed rs776993724, gnomAD rs776993724, CADD 33.00
- Y87H (p.Tyr87His), rs2473110302, ClinGen CA354046753, ClinVar RCV004311566, Uncertain significance, not specified
- Y87Y (p.Tyr87Tyr), rs776993724, gnomAD 3-119544707-G-A, CADD 2.25
- Y87T (p.Tyr87Thr), gnomAD 3-119544708-TA-T, CADD 24.70
- K88Q (p.Lys88Gln), ExAC rs771359795, TOPMed rs771359795, gnomAD rs771359795, REVEL 0.03, MetaLR 0.20
- K88R (p.Lys88Arg), Ensembl rs2107744970, MetaLR 0.20, MetaSVM -0.94
- N89H (p.Asn89His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N89N (p.Asn89Asn), gnomAD 3-119544701-G-A, CADD 7.96
- R90Q (p.Arg90Gln), ExAC rs757278848, TOPMed rs757278848, gnomAD rs757278848, REVEL 0.40, MetaLR 0.42
- R90W (p.Arg90Trp), ExAC rs761204102, TOPMed rs761204102, gnomAD rs761204102, REVEL 0.44, MetaLR 0.42
- R90R (p.Arg90Arg), gnomAD 3-119544698-C-T, CADD 9.65
- R90G (p.Arg90Gly), gnomAD 3-119544700-G-C, REVEL 0.46, MetaLR 0.39
- I92V (p.Ile92Val), gnomAD rs2082190381, REVEL 0.03, MetaLR 0.10
- I92F (p.Ile92Phe), gnomAD 3-119544694-T-A, REVEL 0.04, MetaLR 0.07
- I92L (p.Ile92Leu), gnomAD 3-119544694-T-G, REVEL 0.03, MetaLR 0.11
- F93L (p.Phe93Leu), ExAC rs772241262, gnomAD rs772241262, REVEL 0.04, MetaLR 0.06
- F93F (p.Phe93Phe), gnomAD 3-119544689-A-G, CADD 1.51
- D94N (p.Asp94Asn), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, REVEL 0.21, MetaLR 0.34, Variant assessed as somatic; moderate impact.
- I95I (p.Ile95Ile), gnomAD 3-119544683-G-A, CADD 5.63
- T96I (p.Thr96Ile), ExAC rs748224407, TOPMed rs748224407, gnomAD rs748224407, REVEL 0.05, MetaLR 0.18
- N97H (p.Asn97His), NCI-TCGA Cosmic COSV5180, cosmic curated COSV51801, Variant assessed as somatic; moderate impact.
- N97N (p.Asn97Asn), gnomAD 3-119544677-A-G, CADD 2.12
- p.Asn98 Ser100del, rs1560056708, gnomAD 3-119544668-GGAGA, CADD 17.40
- N98N (p.Asn98Asn), rs779283878, gnomAD 3-119544674-G-A, CADD 7.79
- L99L (p.Leu99Leu), rs116944420, gnomAD 3-119544671-G-C, CADD 2.22
- L99S (p.Leu99Ser), rs770707039, gnomAD 3-119544672-AG-A, CADD 25.20
- S100S (p.Ser100Ser), rs745680949, gnomAD 3-119544668-G-A, CADD 7.66
- I101T (p.Ile101Thr), NCI-TCGA Cosmic COSV9995, cosmic curated COSV99958, Ensembl rs2082190170, MetaLR 0.31, MetaSVM -0.71, Variant assessed as somatic; moderate impact.
Public CD80 analysis runs
- CD80 analysis run — CD80 (623 variants) — completed 2026-08-20